Clene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Clene and other ETFs, options, and stocks.

About CLNN

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington
CEORobert Dee Etherington
Employees
85
Employees85
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
85
Employees85

CLNN Key Statistics

Market cap
55.16M
Market cap55.16M
Price-Earnings ratio
-0.80
Price-Earnings ratio-0.80
Dividend yield
—
Dividend yield—
Average volume
592.42K
Average volume592.42K
High today
$0.4447
High today$0.4447
Low today
$0.42
Low today$0.42
Open price
$0.434
Open price$0.434
Volume
310.20K
Volume310.20K
52 Week high
$1.09
52 Week high$1.09
52 Week low
$0.25
52 Week low$0.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.